Inventia Life Sciences
Australia · $70.1M raised
- Total Funding
- $70.1M
- Last Round
- $3.5M Extension RoundApr 2025
- Rounds
- 4
About
Pioneer in 3D cell culture technology through the RASTRUM platform and comprehensive Discovery Services for phenotypic drug discovery.
Summary
Inventia Life Sciences is a Biotech company based in Australia. It has raised $70.1M in total across 4 rounds, most recently a $3.5M Extension Round round in Apr 2025. Investors include Sonder Capital, Blackbird Ventures and Skip Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...